CEL : Summary for Cellcom Israel, Ltd. Ordinary S - Yahoo Finance

U.S. Markets closed

Cellcom Israel Ltd. (CEL)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
10.20+0.01 (+0.10%)
At close: 4:02PM EDT
People also watch
PTNRHTSCMOTEFIVR
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close10.19
Open10.11
Bid0.00 x
Ask0.00 x
Day's Range10.09 - 10.25
52 Week Range5.70 - 11.19
Volume6,493
Avg. Volume25,806
Market Cap990.75M
Beta2.10
PE Ratio (TTM)25.37
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Cellcom Israel Ltd. :CEL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 24, 2017
    Capital Cube14 hours ago

    Cellcom Israel Ltd. :CEL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 24, 2017

    Categories: Yahoo Finance Get free summary analysis Cellcom Israel Ltd. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Cellcom Israel Ltd. – Turkcell Iletisim Hizmetleri A.S. Sponsored ADR, Millicom International Cellular S.A. and LM Ericsson Telefon AB Sponsored ADR Class B (TKC-US, MIICF-US and ERIC-US) that ... Read more (Read more...)

  • Cellcom Israel Ltd. breached its 50 day moving average in a Bearish Manner : CEL-US : March 22, 2017
    Capital Cube3 days ago

    Cellcom Israel Ltd. breached its 50 day moving average in a Bearish Manner : CEL-US : March 22, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Cellcom Israel Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • Barrons.com3 days ago

    Biotechnology Gets A Shot In the Arm

    The healthcare sector has been doing rather well, gaining 8.9% year-to-date. Behind just information technology, healthcare stocks have outpaced Trump sectors including materials, industrials, and financials so far, suggesting that investors may be getting defensive and they aren't alone. Credit Suisse upgraded its rating on pharmaceuticals/biotechnology to Overweight from Market Weight on Tuesday.